Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Covid19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04025580
What this trial is testing

Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine

Who this might be right for
Healthy Volunteer
National Institute of Allergy and Infectious Diseases (NIAID) 98
Very early researchStudy completedNCT04523246
What this trial is testing

Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents

Who this might be right for
Herpes ZosterAllergy and ImmunologyCorona Virus Infection
University of Oklahoma 217
Early research (Phase 1)Study completedNCT04523571
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects

Who this might be right for
SARS-CoV-2
BioNTech SE 144
Large-scale testing (Phase 3)Study completedNCT07069309
What this trial is testing

Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

Who this might be right for
COVID-19SARS-COV-2 Infection
BioNTech SE 774
Testing effectiveness (Phase 2)Study completedNCT04824638
What this trial is testing

BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers

Who this might be right for
HealthyImmunization; Infection
ANRS, Emerging Infectious Diseases 267
Not applicableStudy completedNCT05386355
What this trial is testing

Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool

Who this might be right for
COVID-19 VaccinesTelemedicineVaccine Hesitancy+1 more
IDeA States Pediatric Clinical Trials Network 1,934
Early research (Phase 1)Study completedNCT04545749
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine

Who this might be right for
COVID-19
United Biomedical Inc., Asia 60
Testing effectiveness (Phase 2)UnknownNCT05542693
What this trial is testing

Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine

Who this might be right for
COVID-19COVID-19 Vaccine
Azidus Brasil 300
Large-scale testing (Phase 3)UnknownNCT05682638
What this trial is testing

A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 34,000
Not applicableStudy completedNCT04775563
What this trial is testing

COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients

Who this might be right for
Covid19
National Institute of Medical Sciences and Nutrition, Salvador Zubiran 891
Large-scale testing (Phase 3)Study completedNCT06409663
What this trial is testing

A Strain Change Study for SARS-CoV-2 rS Vaccines

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Novavax 60
Not applicableStudy completedNCT05543993
What this trial is testing

COVID Booster in Pregnancy and Lactation

Who this might be right for
COVID-19
Thomas Jefferson University 150
Early research (Phase 1)Study completedNCT04691947
What this trial is testing

Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC

Who this might be right for
COVID-19 Vaccine
Health Institutes of Turkey 44
Not applicableUnknownNCT04878796
What this trial is testing

Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV)

Who this might be right for
CancerCovid-19Vaccine Response
Azienda Socio Sanitaria Territoriale di Cremona 300
Not applicableStudy completedNCT04765839
What this trial is testing

Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations

Who this might be right for
Vaccine Preventable Disease
Mayo Clinic 74
Testing effectiveness (Phase 2)Study completedNCT05765773
What this trial is testing

An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and Older

Who this might be right for
Corona Virus InfectionVaccineCOVID-19
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products 200
Large-scale testing (Phase 3)UnknownNCT04350931
What this trial is testing

Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19

Who this might be right for
Coronavirus Disease (COVID-19)
Ain Shams University 900
Testing effectiveness (Phase 2)WithdrawnNCT04845191
What this trial is testing

COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines

Who this might be right for
Covid19
ImmunityBio, Inc.
Not applicableUnknownNCT05680896
What this trial is testing

SARS-CoV-2 Infection Among Healthcare Workers

Who this might be right for
COVID-19
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 600
Not applicableStudy completedNCT05047822
What this trial is testing

Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England

Who this might be right for
Covid-19 Infection
AstraZeneca 18,373,714
Next Page